Share
Corporate
Johnson & Johnson Partners with Save the Children to Help Millions of Children over the Next Three Years
Johnson & Johnson Partners with Save the Children to Help Millions of Children over the Next Three Years
Share
Save the Children named as Enterprise Wide Global Partner

New Brunswick, N.J. (Nov. 19, 2014) — Johnson & Johnson announced today a global partnership with Save the Children that has the potential to help millions of children over the next three years. The $10 million commitment was announced in New York City at Save the Children’s second annual Illumination Gala, where Johnson & Johnson was the presenting sponsor. 

“Tonight marks the beginning of an expanded dedication to Save the Children,” said Alex Gorsky, Chairman and CEO of Johnson & Johnson. “We hope that this partnership will inspire innovation to improve the survival and healthy development of children under age 5, especially newborns.”

The multi-million dollar, multi-year commitment will cover core mission support; program support to improve newborn survival; local activation; and gift-in-kind services. In addition, Johnson & Johnson will continue to support Save the Children in non-monetary ways, including through advocacy/thought leadership, media/awareness building, and employee engagement, among others. 

“For 20 years, Johnson & Johnson has been a committed partner to Save the Children and their significant funding of our programs has created healthier communities and transformed the lives of children all over the world,” said Carolyn Miles, President and CEO of Save the Children. “The announcement of a new global partnership with Johnson & Johnson will help to propel us forward over the next three years, and hopefully another 20 beyond that.”

This global partnership will be executed across the Johnson & Johnson global enterprise. The partnership remains grounded in expanding work around newborn survival, but it goes well beyond to use Johnson & Johnson expertise, reach and influence to affect future generations – wherever they may live. Work with Save the Children is expanding to include even more parts of the Johnson & Johnson Family of Companies in making a meaningful difference for mothers, children and families.

Johnson & Johnson is a lead partner in Save the Children’s newborn programming in support of “Helping Babies Breathe” which saves newborn lives by training birth attendants to address newborn asphyxia – or the inability of a baby to breathe at birth.  The partnership in Uganda and Malawi has trained almost 1000 skilled birth attendants in its first 3 years, mostly midwives, in districts that see over 80,000 births every year.  More than 85 percent of asphyxiated newborns in target districts have been successfully resuscitated. Together, Johnson & Johnson and Save the Children will explore expansion and scale-up of newborn survival programs in Ethiopia and other countries where the need is greatest.

About Johnson & Johnson
Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,000 employees at more than 270 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

About Save the Children
Save the Children gives children in the United States and around the world a healthy start, the opportunity to learn and protection from harm. We invest in childhood — every day, in times of crisis and for our future. Follow us on Twitter and Facebook.

###

Contacts:
Alexandra Holland, Johnson & Johnson
908-200-8275
aholland@its.jnj.com

Phil Carroll, Save the Children
267-992-6356
pcarroll@savechildren.org

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue